These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16044005)

  • 1. The use of community-based modified directly observed therapy for the treatment of HIV-infected persons.
    Mitty JA; Macalino GE; Bazerman LB; Loewenthal HG; Hogan JW; MacLeod CJ; Flanigan TP
    J Acquir Immune Defic Syndr; 2005 Aug; 39(5):545-50. PubMed ID: 16044005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users.
    Macalino GE; Hogan JW; Mitty JA; Bazerman LB; Delong AK; Loewenthal H; Caliendo AM; Flanigan TP
    AIDS; 2007 Jul; 21(11):1473-7. PubMed ID: 17589194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified directly observed therapy to facilitate highly active antiretroviral therapy adherence in Beira, Mozambique. Development and implementation.
    Pearson CR; Micek M; Simoni JM; Matediana E; Martin DP; Gloyd S
    J Acquir Immune Defic Syndr; 2006 Dec; 43 Suppl 1(Suppl 1):S134-41. PubMed ID: 17133197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The feasibility of modified directly observed therapy for HIV-seropositive African American substance users.
    Ma M; Brown BR; Coleman M; Kibler JL; Loewenthal H; Mitty JA
    AIDS Patient Care STDS; 2008 Feb; 22(2):139-46. PubMed ID: 18260805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified directly observed therapy for the treatment of HIV-seropositive substance users: lessons learned from a pilot study.
    Macalino GE; Mitty JA; Bazerman LB; Singh K; McKenzie M; Flanigan T
    Clin Infect Dis; 2004 Jun; 38 Suppl 5():S393-7. PubMed ID: 15156428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence among women with HIV infection in Puerto Rico: the potential use of modified directly observed therapy (MDOT) among pregnant and postpartum women.
    Ciambrone D; Loewenthal HG; Bazerman LB; Zorilla C; Urbina B; Mitty JA
    Women Health; 2006; 44(4):61-77. PubMed ID: 17456464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified directly observed therapy for antiretroviral therapy: a primer from the field.
    Goggin K; Liston RJ; Mitty JA
    Public Health Rep; 2007; 122(4):472-81. PubMed ID: 17639650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A qualitative examination of the indirect effects of modified directly observed therapy on health behaviors other than adherence.
    Bradley-Ewing A; Thomson D; Pinkston M; Goggin KJ
    AIDS Patient Care STDS; 2008 Aug; 22(8):663-8. PubMed ID: 18627279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of directly administered antiretroviral therapy and adherence case management intervention.
    Wohl AR; Garland WH; Valencia R; Squires K; Witt MD; Kovacs A; Larsen R; Hader S; Anthony MN; Weidle PJ
    Clin Infect Dis; 2006 Jun; 42(11):1619-27. PubMed ID: 16652320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a community-based ART programme after tapering home visits in rural Sierra Leone: a 24-month retrospective study.
    Kelly JD; Frankfurter R; Lurton G; Conteh S; Empson SF; Daboh F; Kargbo B; Giordano T; Mukherjee J; Barrie MB
    SAHARA J; 2018 Dec; 15(1):138-145. PubMed ID: 30257611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized control trial of peer-delivered, modified directly observed therapy for HAART in Mozambique.
    Pearson CR; Micek MA; Simoni JM; Hoff PD; Matediana E; Martin DP; Gloyd SS
    J Acquir Immune Defic Syndr; 2007 Oct; 46(2):238-44. PubMed ID: 17693890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrostomy tube insertion for improvement of adherence to highly active antiretroviral therapy in pediatric patients with human immunodeficiency virus.
    Shingadia D; Viani RM; Yogev R; Binns H; Dankner WM; Spector SA; Chadwick EG
    Pediatrics; 2000 Jun; 105(6):E80. PubMed ID: 10835093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Directly observed therapy (DOT) for individuals with HIV: successes and challenges.
    Mitty JA; Macalino G; Taylor L; Harwell JI; Flanigan TP
    MedGenMed; 2003 Feb; 5(1):30. PubMed ID: 12827091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital-based directly observed therapy for HIV-infected children and adolescents to assess adherence to antiretroviral medications.
    Glikman D; Walsh L; Valkenburg J; Mangat PD; Marcinak JF
    Pediatrics; 2007 May; 119(5):e1142-8. PubMed ID: 17452493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and tolerability of a once-daily amprenavir/ritonavir-containing highly active antiretroviral therapy regimen in antiretroviral-naïve patients at risk for nonadherence: 48-week results after 24 weeks of directly observed therapy.
    Jayaweera DT; Kolber MA; Brill M; Tanner T; Campo R; Rodriguez A; Chu HM; Garg V
    HIV Med; 2004 Sep; 5(5):364-70. PubMed ID: 15369512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of asymptomatic HIV-infected patients who discontinued antiretroviral therapy.
    Fernández Guerrero ML; Rivas P; Molina M; Garcia R; De Górgolas M
    Clin Infect Dis; 2005 Aug; 41(3):390-4. PubMed ID: 16007538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing adherence to HAART: a pilot program of modified directly observed therapy.
    Stenzel MS; McKenzie M; Mitty JA; Flanigan TP
    AIDS Read; 2001 Jun; 11(6):317-9, 324-8. PubMed ID: 11449925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy.
    Maru DS; Bruce RD; Walton M; Mezger JA; Springer SA; Shield D; Altice FL
    AIDS Behav; 2008 Mar; 12(2):284-93. PubMed ID: 18085432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.